抄録
Chronic kidney disease-mineral and bone disorder (CKD-MBD) progressively develops from predialysis period. Phosphorus retention, hypocalcemia, and disturbance in activation of vitamin D lead to CKD-MBD. It is important to control the metabolic disorder, so that PTH level can be reduced. Recently, activated form of vitamin D plays important roles not only in calcium metabolism but in ontogenesis, cell differentiation, lipid metabolism and immunoregulation. Vitamin D replacement may be necessary because vitamin D is deficient in patients with predialysis CKD. However, there are possibilities that administration of vitamin D and/or calcium carbonate cause vascular calcification and decrease in residual renal function.
| 本文言語 | 英語 |
|---|---|
| ページ(範囲) | 493-499 |
| ページ数 | 7 |
| ジャーナル | Clinical calcium |
| 巻 | 19 |
| 号 | 4 |
| 出版ステータス | 出版済み - 04-2009 |
| 外部発表 | はい |
All Science Journal Classification (ASJC) codes
- 医学一般
フィンガープリント
「Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver